Objective To systematically review the research progress, key challenges, and clinical translation prospects of xenogeneic liver transplantation in alleviating donor shortage. Method By searching and reviewing relevant literature from domestic and international sources, the current status of xenogeneic liver transplantation research was summarized, focusing on immunological barriers, the development of genetically engineered donor pigs, coagulation dysfunction, physiological compatibility, preclinical studies, and perioperative management strategies. Results The use of multigene-edited pigs has largely overcome hyperacute rejection, with research focus shifting to acute humoral rejection, cellular rejection, and severe coagulation dysfunction resulting from interspecies molecular incompatibility. The combination of genetically engineered donor pigs, novel immunosuppressive regimens centered on anti-CD40 monoclonal antibodies, and refined perioperative management has significantly prolonged graft survival in non-human primate models. Conclusions Xenogeneic liver transplantation offers a promising avenue to address the donor liver shortage. Preclinical studies have preliminarily confirmed its feasibility; however, challenges such as coagulation disorders and physiological incompatibility remain. Future efforts should integrate multigene-modified donors with precise immunomodulation and cross-species physiological support to facilitate clinical translation.
Citation:
GAO Xinyuan, YU Xiaochao, GAO Hongqiang, XU Ronghua. Xenogeneic liver transplantation: progress from basic to preclinical research. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2026, 33(4): 572-577. doi: 10.7507/1007-9424.202511049
Copy
Copyright ? the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
| 1. |
|
| 2. |
|
| 3. |
|
| 4. |
|
| 5. |
|
| 6. |
|
| 7. |
|
| 8. |
|
| 9. |
Meier RPH, Navarro-Alvarez N, Morel P, et al. Current status of hepatocyte xenotransplantation. Int J Surg, 2015, 23(Pt B): 273-279.
|
| 10. |
|
| 11. |
|
| 12. |
|
| 13. |
|
| 14. |
|
| 15. |
|
| 16. |
|
| 17. |
|
| 18. |
|
| 19. |
|
| 20. |
|
| 21. |
|
| 22. |
|
| 23. |
|
| 24. |
|
| 25. |
|
| 26. |
|
| 27. |
Ferdinande K, Campello E, Simioni P, et al. Haemostatic balance and transfusion strategies in acute liver failure and acute-on-chronic liver failure: a systematic review. Liver Int, 2025, 45(11): e70378. doi: 10.1111/liv.70378.
|
| 28. |
|
| 29. |
|
| 30. |
|
| 31. |
|
| 32. |
|
| 33. |
|
| 34. |
|
| 35. |
Zhang W, Qiao G, Yu X, et al. A systematic review and meta-analysis of liver xenotransplantation from genetically modified pigs to nonhuman primates. Int J Surg, 2025, 112 (2): 5120-5131.
|
| 36. |
|
| 37. |
Zhu Y, Tang A, Xiao Q, et al. A milestone in liver xenotransplantation: the first 10-gene-edited pig-to-living-human auxiliary transplantation and the road ahead. Cell Transplant, 2026, 35: 9636897251411036. doi: 10.1177/09636897251411036.
|
| 38. |
|
| 39. |
|
| 40. |
|
| 41. |
|
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
- 9. Meier RPH, Navarro-Alvarez N, Morel P, et al. Current status of hepatocyte xenotransplantation. Int J Surg, 2015, 23(Pt B): 273-279.
- 10.
- 11.
- 12.
- 13.
- 14.
- 15.
- 16.
- 17.
- 18.
- 19.
- 20.
- 21.
- 22.
- 23.
- 24.
- 25.
- 26.
- 27. Ferdinande K, Campello E, Simioni P, et al. Haemostatic balance and transfusion strategies in acute liver failure and acute-on-chronic liver failure: a systematic review. Liver Int, 2025, 45(11): e70378. doi: 10.1111/liv.70378.
- 28.
- 29.
- 30.
- 31.
- 32.
- 33.
- 34.
- 35. Zhang W, Qiao G, Yu X, et al. A systematic review and meta-analysis of liver xenotransplantation from genetically modified pigs to nonhuman primates. Int J Surg, 2025, 112 (2): 5120-5131.
- 36.
- 37. Zhu Y, Tang A, Xiao Q, et al. A milestone in liver xenotransplantation: the first 10-gene-edited pig-to-living-human auxiliary transplantation and the road ahead. Cell Transplant, 2026, 35: 9636897251411036. doi: 10.1177/09636897251411036.
- 38.
- 39.
- 40.
- 41.